Skip to main content

Access to genotypic resistance testing alters physician selection of antiretroviral therapy.

Publication ,  Journal Article
Jones, S; Klotman, ME
Published in: CLINICAL INFECTIOUS DISEASES
July 1, 2000

Duke Scholars

Published In

CLINICAL INFECTIOUS DISEASES

ISSN

1058-4838

Publication Date

July 1, 2000

Volume

31

Issue

1

Start / End Page

275 / 275

Publisher

UNIV CHICAGO PRESS

Related Subject Headings

  • Microbiology
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jones, S., & Klotman, M. E. (2000). Access to genotypic resistance testing alters physician selection of antiretroviral therapy. CLINICAL INFECTIOUS DISEASES, 31(1), 275–275.
Jones, S., and M. E. Klotman. “Access to genotypic resistance testing alters physician selection of antiretroviral therapy.CLINICAL INFECTIOUS DISEASES 31, no. 1 (July 1, 2000): 275–275.
Jones S, Klotman ME. Access to genotypic resistance testing alters physician selection of antiretroviral therapy. CLINICAL INFECTIOUS DISEASES. 2000 Jul 1;31(1):275–275.
Jones, S., and M. E. Klotman. “Access to genotypic resistance testing alters physician selection of antiretroviral therapy.CLINICAL INFECTIOUS DISEASES, vol. 31, no. 1, UNIV CHICAGO PRESS, July 2000, pp. 275–275.
Jones S, Klotman ME. Access to genotypic resistance testing alters physician selection of antiretroviral therapy. CLINICAL INFECTIOUS DISEASES. UNIV CHICAGO PRESS; 2000 Jul 1;31(1):275–275.

Published In

CLINICAL INFECTIOUS DISEASES

ISSN

1058-4838

Publication Date

July 1, 2000

Volume

31

Issue

1

Start / End Page

275 / 275

Publisher

UNIV CHICAGO PRESS

Related Subject Headings

  • Microbiology
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences
  • 06 Biological Sciences